» Articles » PMID: 1827217

Responses to NMDA Receptor Antagonists Altered by Epileptogenesis

Overview
Specialty Pharmacology
Date 1991 Feb 1
PMID 1827217
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

Barker-Haliski M, White H Neuropharmacology. 2019; 167:107750.

PMID: 31469995 PMC: 7470169. DOI: 10.1016/j.neuropharm.2019.107750.


Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Loscher W Neurochem Res. 2017; 42(7):1873-1888.

PMID: 28290134 DOI: 10.1007/s11064-017-2222-z.


The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?.

Loscher W Neurochem Res. 2016; 42(7):1926-1938.

PMID: 27502939 DOI: 10.1007/s11064-016-2025-7.


New avenues for anti-epileptic drug discovery and development.

Loscher W, Klitgaard H, Twyman R, Schmidt D Nat Rev Drug Discov. 2013; 12(10):757-76.

PMID: 24052047 DOI: 10.1038/nrd4126.


The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.

Boehlen A, Schwake M, Dost R, Kunert A, Fidzinski P, Heinemann U Br J Pharmacol. 2012; 168(5):1182-200.

PMID: 23176257 PMC: 3594676. DOI: 10.1111/bph.12065.